• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例慢性自发性荨麻疹,风团持续超过一周。

A case of chronic spontaneous urticaria with wheals lasting for more than a week.

作者信息

Morioke Satoshi, Moriwaki Masaya, Tanaka Akio, Hide Michihiro

机构信息

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Department of Dermatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.

出版信息

J Dermatol. 2025 Feb;52(2):344-347. doi: 10.1111/1346-8138.17480. Epub 2024 Sep 30.

DOI:10.1111/1346-8138.17480
PMID:39349975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11807357/
Abstract

Urticaria is characterized by the development of wheals which usually disappear within a day, and are not present beyond a few days. A 58-year-old man began to develop edematous, partially ring-shaped erythematous lesions accompanied by severe body itching without any particular cause, approximately 2 months before his first visit to our hospital. Each rash emerged as being about 5 mm in diameter, gradually enlarging over several days, and disappeared in up to 10 days. Despite oral treatment with several antihistamines and 10 mg of prednisolone, there was no improvement. Most eruptions disappeared without a trace, but the erythema that appeared on the palms left desquamation. The patient had a history of shellfish allergy, but otherwise no atopic diseases. Drug eruption was ruled out due to a lack of regular taking other medications. Histopathological findings of the skin lesions showed moderate lymphocytic and few eosinophilic infiltrates with edema, but no evidence of vasculitis. Despite the concomitant use of two second-generation antihistamines and montelukast, the rash did not improve. The symptoms began to improve following oral intake of 1.5 mg of betamethasone, which was tapered off with the addition of 150 mg of cyclosporin. The use of all medications was stopped at 4 months from the first visit without recurrence. Wheals of chronic spontaneous urticaria may last for longer than a week without apparent histopathological findings of vasculitis.

摘要

荨麻疹的特征是出现风团,风团通常在一天内消失,且不会持续超过几天。一名58岁男性在首次就诊于我院前约2个月开始出现水肿性、部分呈环形的红斑性皮损,并伴有严重的全身瘙痒,无任何特殊原因。每次皮疹出现时直径约5毫米,数天内逐渐增大,最多10天内消失。尽管口服了几种抗组胺药和10毫克泼尼松龙,但病情并无改善。大多数皮疹消退后不留痕迹,但手掌上出现的红斑留下了脱屑。患者有贝类过敏史,但无其他特应性疾病。由于没有规律服用其他药物,排除了药疹。皮肤病变的组织病理学检查结果显示有中度淋巴细胞浸润和少量嗜酸性粒细胞浸润伴水肿,但无血管炎证据。尽管同时使用了两种第二代抗组胺药和孟鲁司特,但皮疹仍未改善。口服1.5毫克倍他米松后症状开始改善,加用150毫克环孢素后逐渐减量。从首次就诊起4个月时停用所有药物,未再复发。慢性自发性荨麻疹的风团可能持续超过一周,且无明显的血管炎组织病理学表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b732/11807357/06e22191b37a/JDE-52-344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b732/11807357/994b71be8024/JDE-52-344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b732/11807357/c5880ce4467e/JDE-52-344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b732/11807357/06e22191b37a/JDE-52-344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b732/11807357/994b71be8024/JDE-52-344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b732/11807357/c5880ce4467e/JDE-52-344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b732/11807357/06e22191b37a/JDE-52-344-g001.jpg

相似文献

1
A case of chronic spontaneous urticaria with wheals lasting for more than a week.一例慢性自发性荨麻疹,风团持续超过一周。
J Dermatol. 2025 Feb;52(2):344-347. doi: 10.1111/1346-8138.17480. Epub 2024 Sep 30.
2
Chronic spontaneous urticaria, treatment with antihistamines.慢性自发性荨麻疹,抗组胺药治疗
Ceska Slov Farm. 2024;73(1):13-15. doi: 10.36290/csf.2024.002.
3
Chronic Urticaria: An Overview of Treatment and Recent Patents.慢性荨麻疹:治疗概述与近期专利
Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):27-37. doi: 10.2174/1872213X13666190328164931.
4
From Research to Practice: The Latest Data on Evolving Treatments for Chronic Spontaneous Urticaria.从研究到实践:慢性自发性荨麻疹治疗方法最新数据。
J Drugs Dermatol. 2024 Sep 1;23(9):795-806.
5
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.胆碱能性荨麻疹中靶向组胺受体 4 的 izuforant(LEO 152020):一项 IIa 期随机、双盲、安慰剂对照、多中心交叉试验的结果。
Br J Dermatol. 2024 May 17;190(6):825-835. doi: 10.1093/bjd/ljae038.
6
Pressure challenge test and histopathological inspections for 17 Japanese cases with clinically diagnosed delayed pressure urticaria.17 例临床诊断为迟发性压力性荨麻疹患者的压力挑战试验和组织病理学检查。
Arch Dermatol Res. 2010 Oct;302(8):613-7. doi: 10.1007/s00403-010-1053-4. Epub 2010 May 18.
7
Histopathology of chronic spontaneous urticaria with occasional bruising lesions is not significantly different from urticaria with typical wheals.慢性自发性荨麻疹偶有瘀斑皮损的组织病理学与典型风团性荨麻疹并无显著差异。
J Cutan Pathol. 2021 Aug;48(8):1020-1026. doi: 10.1111/cup.13985. Epub 2021 Mar 15.
8
Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.儿童慢性自发性荨麻疹患者使用标准剂量第二代 H1 抗组胺药后症状控制不佳的风险因素。
Asian Pac J Allergy Immunol. 2022 Jun;40(2):121-125. doi: 10.12932/AP-030619-0573.
9
Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.慢性自发性荨麻疹的当前和新兴药物治疗:关注非生物疗法。
Expert Opin Pharmacother. 2021 Mar;22(4):497-509. doi: 10.1080/14656566.2020.1829593. Epub 2021 Feb 22.
10
Mizoribine treatment for antihistamine-resistant chronic autoimmune urticaria.吗替麦考酚酯治疗抗组胺药物抵抗性慢性自身免疫性荨麻疹。
Dermatol Ther. 2012 Jul-Aug;25(4):379-81. doi: 10.1111/j.1529-8019.2012.01468.x.

本文引用的文献

1
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey.荨麻疹性血管炎与慢性自发性荨麻疹的鉴别诊断:一项国际德尔菲调查。
Clin Transl Allergy. 2023 Oct;13(10):e12305. doi: 10.1002/clt2.12305.
2
Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study.荨麻疹性血管炎与慢性自发性荨麻疹在诊断时间、临床表现和抗炎治疗需求方面存在差异:一项国际前瞻性 UCARE 研究。
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2900-2910.e21. doi: 10.1016/j.jaip.2023.06.030. Epub 2023 Jun 24.
3
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
国际 EAACI/GA²LEN/EuroGuiDerm/APAAACI 荨麻疹定义、分类、诊断和管理指南。
Allergy. 2022 Mar;77(3):734-766. doi: 10.1111/all.15090. Epub 2021 Oct 20.
4
Management of urticarial vasculitis: A worldwide physician perspective.荨麻疹性血管炎的管理:全球医生视角
World Allergy Organ J. 2020 Mar 5;13(3):100107. doi: 10.1016/j.waojou.2020.100107. eCollection 2020 Mar.
5
Pressure challenge test and histopathological inspections for 17 Japanese cases with clinically diagnosed delayed pressure urticaria.17 例临床诊断为迟发性压力性荨麻疹患者的压力挑战试验和组织病理学检查。
Arch Dermatol Res. 2010 Oct;302(8):613-7. doi: 10.1007/s00403-010-1053-4. Epub 2010 May 18.
6
"Lymphocytic vasculitis" is not urticarial vasculitis.“淋巴细胞性血管炎”并非荨麻疹性血管炎。
J Am Acad Dermatol. 2008 Aug;59(2):353. doi: 10.1016/j.jaad.2008.02.028.
7
Delayed pressure urticaria.迟发性压力性荨麻疹。
J Investig Dermatol Symp Proc. 2001 Nov;6(2):148-9. doi: 10.1046/j.0022-202x.2001.00030.x.